BN Business News
Add your company to Business Communicator →

Business · 14/03/2017Updated: 10/17/2026 · 1 min read

FDA Classifies Continuous Glucose Monitor Secondary Display into Class II, Special Controls

Summary

The FDA is classifying the continuous glucose monitor secondary display into Class II, Special Controls, to ensure the device's safety and effectiveness. This classification will apply to the device's special controls, which are outlined in the codified language.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →